Our community narratives are driven by numbers and valuation.
Price Structure & Momentum. Alpha IVF is currently pivoting from a consolidation phase into a high-potential recovery setup, trading at RM 0.295.Read more
Alpha IVF Group Berhad is starting to look like one of those healthcare counters where the market may be undervaluing the business in P/E terms by focusing too much on near-term margin pressure and not enough on its medium-term earnings power. At current valuation levels, the stock does not appear excessively demanding for a company that is still profitable, generates strong returns, and is expanding its footprint across Southeast Asia.Read more
Sunway Healthcare’s listing has clearly reset the market’s valuation benchmark for private healthcare counters in Malaysia. At IPO, Sunway Healthcare was already being priced at around RM16.7 billion market capitalisation , equivalent to about 64.8 times FY2024 earnings , and after its strong debut its market value reportedly rose further to around RM21.3 billion.Read more
IHH is leaning harder into shorter-stay treatments and tighter operations to cut costs while expanding newer hospitals and attracting more overseas patients. That mix could lift results, but it also leaves the business exposed to insurer pushback, deal-making risks, currency swings, and any slowdown in medical tourism.Read more
